While you’re here… help us stay here.
Are you enjoying open access to policy and research published by a broad range of organisations? Please donate today so that we can continue to provide this service.
|s100 Survey report: HIV antiretroviral (ART) co-payment initiative||1.37 MB|
In 2015, the NSW government enacted its pre-election commitment to waive the pharmaceutical benefits scheme (PBS) co-payment for s100 HIV antiretroviral medications in NSW. This meant people living with HIV (PLHIV) were no longer required to pay a co-payment for their HIV medications.
Five years later, the NSW Ministry of Health (NSW Health) approached Positive Life to find out PLHIV's experiences of the co-payment waiver and understand the best way to continue the administration of the co-payment initiative into the future. In October 2020, Positive Life NSW (Positive Life) consulted with PLHIV in NSW via a community survey.
This HIV antiretroviral (ART) Co-payment Initiative Survey Report: